T. Yamanoi et al. / Tetrahedron: Asymmetry 17 (2006) 2914–2918
2917
yields. The stereoselectivities of the glycosidic linkages
during the ketopyranosylation were also clarified.
H-50), 5.24 (1H, d, J = 2.1 Hz, H-10); 13C NMR (CDCl3):
d 23.0 (CH3), 68.6 (C-6), 69.1 (C-60), 71.6 (C-50), 72.2 (C-
5), 75.23 (C-40 or C-20 or CH2Ph), 75.25 (C-40 or C-20 or
CH2Ph), 75.36 (C-40 or C-20 or CH2Ph), 75.37 (C-40 or
C-20 or CH2Ph), 78.2 (C-4), 79.7 (C-30), 82.9 (C-3), 84.6
(C-2), 90.7 (C-10), 101.2 (C-1, JC1–H1 = 168 Hz); HRMS
(ESI): m/z calcd for C69H72O11Na+: 1099.4967; found:
1099.5009.
4. Experimental
4.1. General
The NMR spectra were measured using an ECA-600
(JEOL) spectrometer at 600 MHz (1H), and 150 MHz
4.2.3. 2-Azido-3,4,6-tri-O-benzyl-2-deoxy-a and b-D-gluco-
pyranosyl 2,3,4,6-tetra-O-benzyl-1-C-methyl-a-D-glucopyr-
anoside 8. Colorless oil (a,b-mixture); a-form; H NMR
1
(13C). The H NMR chemical shifts are referenced to the
internal standard TMS (dH = 0.00). The 13C NMR chemi-
cal shifts are referenced to the solvent signal (dC = 77.0 for
the central line of CDCl3). The ESI-MS spectra were
recorded using a Mariner (Applied Biosystems) spectro-
meter. Optical rotations were recorded using a JASCO
DIP-360 digital polarimeter. All reactions were monitored
by thin-layer chromatography (TLC) using Merck silica gel
60 F254 precoated plates (0.25 mm).
1
(CDCl3): d 1.47 (3H, s, CH3), 5.26 (1H, d, J = 3.4 Hz, H-
10), 3.29 (1H, d, J = 9.6 Hz, H-2); 13C NMR (CDCl3): d
23.0 (CH3), 90.6 (C-10), 101.2 (C-1); b-form; 1H NMR
(CDCl3): d 1.49 (3H, s, CH3), 4.61 (1H, d, J = 6.9 Hz, H-
10), 3.30–3.39 (1H, m, H-2); 13C NMR (CDCl3): d 22.3
(CH3), 95.7 (C-10), 102.6 (C-1); HRMS (ESI): m/z calcd
for C62H65O10N3Na+: 1034.4562; found: 1034.4598 (a, b-
mixture).
4.2. General synthesis of 3 by the ketopyranosylation of 1
with 2
4.2.4. 2,3,4,6-Tetra-O-benzyl-a and b-D-galactopyranosyl
2,3,4,6-tetra-O-benzyl-1-C-methyl-a-D-glucopyranoside 9.
23
To a stirred solution of Bi(OTf)3 (4.4 mg, 0.0067 mmol)
and 2 (48.3 mg, 0.0893 mmol) in CH2Cl2 (3.5 mL) was
added 1 (79.3 mg, 0.134 mmol) at 0 °C in the presence of
Drierite (ca. 100 mg) under an Ar atmosphere. The result-
ing mixture was stirred for 3 h. The reaction was then
quenched by the addition of a satd NaHCO3 solution
(5 mL). The reaction mixture was extracted with ethyl ace-
tate, and the organic layer was washed with water and a
satd NaCl solution. After the organic layer was dried over
Na2SO4, the solvent was evaporated under reduced pres-
sure. The crude product was purified by preparative silica
gel TLC (ethyl acetate/hexane = 1/3) to give 3 as a color-
less oil (85.3 mg, 89%).
a-Form; Colorless oil; ½aꢀD ¼ þ74 (c 0.95, CHCl3); 1H
NMR (CDCl3): d 1.47 (3H, s, CH3), 3.26 (1H, d,
J = 9.6 Hz, H-2), 3.28–3.33 (2H, m, H-6), 3.47 (1H,
dd, J = 6.2 Hz, J = 9.6 Hz, H-60a) 3.55 (1H, dd, J =
7.6 Hz, J = 8.9 Hz, H-60b), 3.63 (1H, dd, J = 9.6 Hz,
J = 10.3 Hz, H-4), 3.93 (1H, dd, J = 8.9 Hz, J = 9.6 Hz,
H-3), 4.02 (1H, d, J = 0.7 Hz, H-30 or H-40), 4.06–4.07
(2H, m, H-20, H-30 or H-40), 4.31–4.33 (1H, m, H-5),
4.34–4.37 (1H, m, H-50), 5.36 (1H, d, J = 1.4 Hz, H-10);
13C NMR (CDCl3): d 22.8 (CH3), 68.4 (C-6), 69.0 (C-60),
69.2 (C-50), 70.9 (C-5), 74.9 (C-30 or C-40), 76.8 (C-20 or
C-30 or C-40), 78.4 (C-4), 78.6 (C-20 or C-30 or C-40), 83.0
(C-3), 85.1 (C-2), 90.9 (C-10), 100.8 (C-1); HRMS (ESI):
m/z calcd for C69H72O11Na+: 1099.4967; found:
23
4.2.1. 2,3,4,6-Tetra-O-benzyl-a-D-glucopyranosyl 2,3,4,6-
tetra-O-benzyl-1-C-methyl-a-D-glucopyranoside 3. Colorless
1099.4985. b-Form; colorless oil; ½aꢀD ¼ þ48 (c 0.70,
CHCl3); 1H NMR (CDCl3): d 1.45 (3H, s, CH3), 3.34
(1H, d, J = 9.6 Hz, H-2), 3.45–3.53 (4H, m, H-30 or H-40,
H-50, H-6a, H-6b), 3.60–3.66 (2H, m, H-60), 3.70 (1H, t,
J = 9.6 Hz, H-4), 3.80–3.84 (2H, m, H-20, H-30, or H-40),
4.19 (1H, t, J = 9.6 Hz, H-3), 4.32–4.37 (3H, m, CH2Ph,
H-5), 4.70 (1H, d, J = 6.9 Hz, H-10); 13C NMR (CDCl3):
d 22.4 (CH3), 68.6 (C-60), 69.0 (C-6), 72.1 (C-5), 73.6 (C-
50), 73.8 (C-20 or C-30 or C-40), 78.7 (C-4), 79.0 (C-20 or
C-30 or C-40), 82.4 (C-20 or C-30 or C-40), 82.9 (C-3), 84.5
(C-2), 97.6 (C-10), 102.3 (C-1); HRMS (ESI): m/z calcd
for C69H72O11Na+: 1099.4967; found: 1099.4975.
23
1
oil; ½aꢀD ¼ þ70 (c 2.0, CHCl3); H NMR (CDCl3): d 1.49
(3H, s, CH3), 3.29 (1H, d, J = 9.6 Hz, H-2), 3.33–3.39 (3H,
m, H-6a, H-6b, H-60a), 3.55–3.58 (1H, m, H-60b), 3.56
(1H, dd, J = 10.3 Hz, J = 3.4 Hz, H-20), 3.64 (1H, dd,
J = 9.6 Hz, J = 10.3 Hz H-4), 3.68 (1H, t, J = 9.6 Hz, H-
40), 4.03 (1H, t, J = 10.3 Hz, H-3), 4.05 (1H, t, J = 9.6 Hz,
H-30), 4.17–4.19 (1H, m, H-50), 4.29–4.28 (1H, m, H-5),
5.34 (1H, d, J = 3.4 Hz, H-10); 13C NMR (CDCl3): d 22.7
(CH3), 68.3 (C-60), 68.5 (C-6), 70.0 (C-50), 71.0 (C-5), 78.0
(C-40), 78.5 (C-4), 80.1 (C-20), 81.8 (C-3), 82.7 (C-30), 85.1
(C-20), 90.2 (C-10), 101.0 (C-1); HRMS (ESI): m/z calcd for
C69H72O11Na+: 1099.4967; found: 1099.5006.
4.2.5. 2,3,4,6-Tetra-O-benzyl-a-D-glucopyranosyl 2,3,4,6-
tetra-O-benzyl-1-C-methyl-a-D-mannopyranoside 11. Col-
23
1
4.2.2. 2,3,4,6-Tetra-O-benzyl-a-D-mannopyranosyl 2,3,4,6-
tetra-O-benzyl-1-C-methyl-a-D-glucopyranoside 7. Color-
orless oil; ½aꢀD ¼ þ57 (c 0.81, CHCl3); H NMR (CDCl3):
1H NMR (CDCl3): d 1.46 (3H, s, CH3), 3.50–3.51 (2H, m,
H-60), 3.54–3.58 (3H, m, H-6a, H-40, H-20), 3.66 (1H, t,
J = 9.6 Hz, H-4), 3.72 (1H, dd, J = 3.4 Hz, J = 10.3 Hz,
H-6b), 3.77–3.78 (1H, m, H-5), 3.89 (1H, dd, J = 8.9 Hz,
J = 9.6 Hz, H-30), 3.94 (1H, dd, J = 9.6 Hz, J = 10.3 Hz,
H-3), 4.16 (1H, dd, J = 2.1 Hz, J = 9.6 Hz, H-2), 4.18–
4.21 (1H, m, H-50), 5.42 (1H, d, J = 3.4 Hz, H-10); 13C
NMR (CDCl3): d 22.5 (CH3), 68.5 (C-6), 69.3 (C-60), 70.5
(C-5), 72.9 (C-50), 74.8 (C-3), 77.9 (C-4), 79.1 (C-20), 80.1
23
1
less oil; ½aꢀD ¼ þ59 (c 0.83, CHCl3); H NMR (CDCl3): d
1.46 (3H, s, CH3), 3.23 (1H, d, J = 9.6 Hz, H-2), 3.29–
3.31 (1H, m, H-5), 3.44 (1H, d, J = 10.3 Hz, H-6a), 3.52–
3.54 (2H, m, H-6b, H-20), 3.56 (1H, dd, J = 8.9 Hz,
J = 10.3 Hz, H-4), 3.61 (1H, d, J = 10.3 Hz, H-60a), 3.70–
3.72 (1H, m, H-60b), 3.74 (1H, dd, J = 8.9 Hz,
J = 10.3 Hz, H-3), 3.96 (1H, dd, J = 2.8 Hz, J = 10.3 Hz,
H-30), 4.00 (1H, t, J = 9.6 Hz, H-40), 4.07–4.10 (1H, m,